Quad Cities Investment Group, LLC Sarepta Therapeutics, Inc. Transaction History

Quad Cities Investment Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 28, 2020	SELL	$76.53 - $135.58 $30,612 - $54,232	-400 Closed	0 $0
Q3 2019 Oct 25, 2019	BUY	$72.81 - $156.91 $14,562 - $31,382	200 Added 100.0%	400 $301,000
Q2 2019 Jul 17, 2019	SELL	$112.21 - $151.95 $22,442 - $30,389	-200 Reduced 50.0%	200 $30,000
Q1 2019 Apr 09, 2019	BUY	$106.67 - $151.68 $21,334 - $30,336	200 Added 100.0%	400 $48,000
Q2 2018 Aug 07, 2018	BUY	$71.74 - $153.69 $14,347 - $30,738	200 New	200 $26,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Quad Cities Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Quad Cities Investment Group, LLC with notifications on news.